CIK 0001869105 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BridgeBio Oncology Therapeutics, Inc.
Sign in to watch- Ticker
- BBOT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857 702 0377
- Business address
- 256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Helix Acquisition Corp. II
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Principal Accounting Officer gave up 203 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 126 shares (to pay taxes)
- 4 Shares withheld for taxes COO & Principal Financial Ofcr gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Med & Dev Officer gave up 1,047 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 203 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- S-3 Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Principal Accounting Officer gave up 125 shares (to pay taxes)
- 4 Shares withheld for taxes COO & Principal Financial Ofcr gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Med & Dev Officer gave up 1,047 shares (to pay taxes)
Page 1 of 10 · 187 filings